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by age groups of 60 to 74. ConClusions: The physiotherapy services occurred with 
the highest incidence in cases of the ‘diseases of the musculoskeletal system and 
connective tissue’ ICD group. The dorsopathia diseases at the ICD groups show the 
highest prevalence, indicating the importance of prevention.
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objeCtives: The medical aspects of injuries of the lower extremity is well known, 
however, limited information is available on physiotherapy treatment of these dis-
eases. The aim of our study is to assess amount and frequency of the physiotherapy 
services in hip and thigh injuries based on age and gender distribution. Methods: 
Data were derived from the countrywide database of Hungarian Health Insurance 
Administration (HHIA), based on official reports of outpatient care institutes in 
2009. The total numbers of different physiotherapy services were determined by 
selecting the reported specific diagnoses codes and counting the number treatments 
provided for that specific diagnosis code. The different types of treatment codes 
are listed in the chapter of the Guidelines of HHIA for ‘Physiotherapists, massage-
therapists, conductors and other physiotherapy practices’. The number of cases 
in physiotherapy activities related to for hip and thigh injuries (BNO S70-79) were 
determined per 10,000 persons by age and gender in outpatient care. Results: 
The total number of the 151 different physiotherapy services was 353.260 cases at 
the hip and thigh injuries in the year of 2009 at the. In 2009 the average number of 
cases of physiotherapy activities per 10,000 persons accounted for 351.91 cases. The 
average number of cases per 10,000 persons for males and females were 443.7 cases 
for males and 249.75 cases for females. The number of cases of the hip and thigh 
injuries were higher in the 15-49 age group in males, and in the age group of elderly 
females. ConClusions: In case of the hip and thigh injuries, the highest demand 
of the outpatient care physiotherapy services occurred older injured patients. The 
differences in young males vary with the physical activity and the type of recreation 
activities, and with the condition of osteoporosis in elderly females.
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objeCtives: With an aging population, prevalence of OP and OP-attributable frac-
tures (OAF) is expected to rise dramatically. We evaluated prevalence and treatment 
rates for male OP (MOP) in Germany. Methods: BEST, a retrospective analysis of 
de-identified claims data from a German sickness fund, included male and female 
OP patients, aged ≥ 50 years and insured ≥ 1 day between 01/2006−12/2009. Two 
populations were defined. Inclusion criteria for population B were: 1) OP diagno-
sis (M80.x, M81.x), and/or 2) prescription for OP-related medication (OPM), and 3) 
exclusion of diagnoses M88.x, E83.5x, and M90.7x (ICD-10). Population A included 
population B plus patients solely experiencing OAF. Results: Population A included 
104,938 men. In 2009, prevalence of MOP was 6%. While 67% of men experienced 
≥ 1 OAF during observation period, with the highest rate in those aged 50-54 years 
(78%), only 15% received OPM. Population B included 47,694 men. In 2009 prevalence 
of MOP was 4.8%. 27.2% of those diagnosed experienced ≥ 1 OAF, with the highest 
rate in men aged ≥ 75 years (2006-2009). Only 41.8% of men with ≥ 1 OAF received 
OPM during the observation period. ConClusions: While prevalence of MOP is 
lower than that of postmenopausal OP (6% vs. 24% in 2009), high fracture rates 
in OP-patients represent a significant burden to the German health care system. 
The low treatment rates reported may lead to suboptimal outcomes, and must be 
optimized to reduce risk of follow-up fractures in MOP.
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objeCtives: Using a benefit-harm frontier (BHF) approach, we systematically com-
pared benefits and harms of different HPV- and cytology-based primary cervical can-
cer screening strategies in Germany. Methods: A previously validated and published 
Markov modelwas used to analyze the trade-off between benefits and harms of differ-
ent screening strategies differing by length of screening interval and test algorithms, 
including cytology alone, HPV testing alone, in combination with cytology or with 
cytological triage of HPV-positives. We used published German clinical, epidemio-
logical and international test accuracy data from meta-analyses. Predicted outcomes 
included reduction in cervical cancer incidence and unnecessary treatment (defined 
as conizations of lesions < CIN3). Results: Overall, comparing identical screening 
Metabolism, Metabolic Bone Centre, University of Sheffield, Sheffield, UK, 11Department of 
Medicine, NorthWest Academic Centre, The University of Melbourne, Melbourne, Australia, 
12INSERM U1059, CHU-St-Etienne, Saint Etienne, France, 13LIME/MMC, Karolinska Institutet, 
Stockholm, Sweden, 14WHO Collaborating Centre for Metabolic Bone Diseases, University of 
Sheffield, Sheffield, UK
objeCtives: The International Costs and Utilities Related to Osteoporotic fractures 
Study (ICUROS) is an ongoing 18 months prospective observational study with the 
objective of estimating resource use and health related quality of life related to 
osteoporotic fractures. This study aims to describe the resource utilization for hip 
fractures (sustained during 2007-2012) pooled from 10 countries: Australia, Austria, 
Estonia, France, Italy, Lithuania, Mexico, Russia, Spain, and the UK. Methods: 
Patients studied were ≥ 50 years and lived at home prior to fracture. Data were col-
lected through patient interviews and review of medical records: at baseline and 4, 
12, and 18 months after fracture. Only resource use related to the fracture event was 
collected. Results: There were 1,795, 1,435, 1,256 patients available for analysis at 4, 
12 and 18 months follow-up, respectively. The mean age (±SD) at fracture was 77±10 
years and 79% were women. 96% of patients were hospitalized. Mean hospital length 
of stay (LoS) (±SD) was 17.2±20.4 days during months 0-4 and 1.2±6.8 during months 
5-18. Mean LoS varied from 9.3 days to 26.5 days during months 0-4 across countries. 
The mean number of physician visits (±SD) was 2.8±3.1 during months 0-4 and 
2.5±5.6 between months 5-18. The mean number of nurse visits (±SD) was 2.4±9.6 
and 3.8±31.9 during corresponding periods, respectively. During months 0-4, 65% of 
patients used analgesics, 41% calcium/vitamin D, and 27% pharmacological inter-
ventions for osteoporosis. The respective uptakes for months 5-18 were 47%, 46% 
and 25%. ConClusions: Almost all patients were hospitalized after fracture and 
the mean number of inpatient days is high, although there is a large variation. The 
vast majority of health care consumption in relation to fracture occurs during the 
first 4 months but substantial consumption persists up to 18 months after fracture.
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objeCtives: The diagnosis and management of PMO involves multiple special-
ists and referrals. To better understand patient management, an ongoing obser-
vational study will evaluate the care map of women with PMO treated in routine 
clinical practice in Switzerland, and estimate the 2-year treatment cost of parenter-
ally administered medications (denosumab, ibandronate, zoledronate). Here, we 
describe the study design and methodology. Methods: Of 52 specialist centers 
across Switzerland operating a DXA machine, 22 agreed to participate in the study. 
Women diagnosed with PMO and initiated on parenteral antiresorptive treatment 
were enrolled in the study between June 18, 2012 and May 31, 2013. To minimize 
selection bias, treatment initiation must have occurred within 6 months before 
study initiation visit at the participating center. The planned follow-up period is 24 
months. Patients may be followed by the specialist or referred back to the general 
practitioner. Where available, the following data will be collected: demographics and 
patient history, co-morbidities and co-medications, DXA T-scores, osteoporosis risk 
factors, PMO treatment and rationale, bone turnover markers, vitamin D level, and 
costs related to PMO diagnosis and treatment. These parameters will be recorded 
at baseline and at any visit in the 24-month observation period as available from 
routine practice. Continuous outcomes will be summarized by descriptive statistics. 
For categorical outcomes, the number and percentage of patients in each category 
will be presented. Baseline covariates (demographic, patient characteristics and site 
characteristics) will be described overall and by treatment received. Results: As 
of May 31, 2013 at least 280 eligible women were enrolled into the study. Full study 
results will be reported at a later date. ConClusions: The recruited number of 
patients confirms the feasibility of the planned methodology. Data from this study 
will provide valuable information regarding the care map of women with PMO in 
routine clinical practice in Switzerland.
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objeCtives: To assess the utilization of out-patient care physiotherapy services 
related to dorsopathia diseases of the musculoskeletal and connective tissue dis-
eases according to age and gender. Methods: The data come from the financial 
data base of the National Health Insurance Fund Administration (in Hungarian: 
OEP) involving the year of 2009. The activity list was provided by the rulebook on 
the application of the activity code list in out-patient care. The dorsopathia dis-
eases of musculoskeletal and connective tissue diseases (M00-M99) are listed in the 
International Classification of Diseases (ICD) with code of M40–M54. The number 
of cases in physiotherapy activities were determined per 10,000 persons by age 
and gender in outpatient care. Results: The total number of the provided 151 dif-
ferent types WHO-classified physiotherapy services was 32.318.413 in the year of 
2009; 19.095.614 (59,09%) of them with the musculoskeletal and connective tissue 
diseases. The prevalence of the dorsopathia diseases were 51,17% in the group of 
the muskuloskeletal and connective tissue diseases. The average number of cases 
of physiotherapy activities per 10,000 persons accounted for 12.015 cases in 2009. 
The average number of cases per 10,000 persons for males and females were 15.589 
cases for males and 8.061 cases for females. The number of cases increase from 
the 20. age groups in the men and women patients. The highest number of physi-
otherapy treatment is provided for both gender in the age group 50 to 59 followed 
